Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 02-2021 | 12-2020 | 11-2020 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 347 | 52 | N/A | 52 |
| Other current assets | 0 | 78 | 0 | 78 |
| TOTAL | $634 | $129 | $N/A | $129 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 115,326 | 0 | 0 | 0 |
| TOTAL | $115,326 | $N/A | $N/A | $N/A |
| Total Assets | $115,960 | $129 | $N/A | $129 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 14 | 0 | 0 | 0 |
| Accrued Expenses | 35 | 29 | N/A | 29 |
| Other current liabilities | N/A | 270 | N/A | 270 |
| TOTAL | $49 | $299 | $N/A | $299 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 115,349 | 0 | 0 | 0 |
| TOTAL | $115,349 | $N/A | $N/A | $N/A |
| Total Liabilities | $115,397 | $299 | $N/A | $299 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 110 | N/A | N/A | N/A |
| Retained earnings | -294 | -196 | N/A | -196 |
| TOTAL | $563 | $-170 | $N/A | $-170 |
| Total Liabilities And Equity | $115,960 | $129 | $0 | $129 |